Pediatric anesthesia & critical care
Bleeding and ketorolac use in pediatric circumcision
Main finding · Postoperative bleeding requiring interventionResult — go to the resultDifference 0.6% 95% CI −0.8% to 2.0%Authors' conclusion
There was no statistically significant difference in postoperative bleeding requiring intervention between the non-ketorolac and ketorolac groups.
Study context
- Population
- Pediatric patients 1–18 years undergoing isolated circumcision by one urologist, 2016 to 2020
- Participants
- 743 patients
- Exposure
- Intraoperative ketorolac vs no ketorolac
- Ketorolacn = 429
- Non-ketorolacn = 314reference
- Outcome
- Clinically significant bleeding (bleeding requiring intervention: absorbable hemostats, sutures, or return to the OR)
- Follow-up
- First 24 h
Methodological detailssingle-centre, single urologist
- Single-centre
- Single urologist
Main finding
Postoperative bleeding requiring intervention
Difference
0.6%
95% CI −0.8% to 2.0%
P = 0.403
Events by group
Ketorolac vs Non-ketorolac
difference 0.6% (95% CI −0.8% to 2.0%); P = 0.403
As reported in the abstract
Observational data: associations, not effects.
Original publication
Bleeding and ketorolac use in pediatric circumcision. Paediatr Anaesth. Published 29 March 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →